NASDAQ: DTIL
Precision Biosciences Inc Stock Ownership - Who owns Precision Biosciences?

Insider buying vs selling

Have Precision Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John Alexander KellyChief Financial Officer2025-07-0314,827$4.26
$63.16kSell
Melinda BrownDirector2025-06-251,682$4.14
$6.96kBuy
Kevin BuehlerDirector2025-06-255,076$4.16
$21.12kBuy
Melinda BrownDirector2025-03-261,839$4.75
$8.74kBuy
Kevin BuehlerDirector2025-03-264,523$4.67
$21.12kBuy
Geno J. GermanoDirector2025-03-253,250$5.30
$17.23kBuy
Michael AmorosoPresident and CEO2025-03-24964$5.56
$5.36kSell
J. Jefferson SmithChief Research Officer2025-03-04154$4.91
$756.14Sell
Dario ScimecaGeneral Counsel and Secretary2025-03-04272$4.91
$1.34kSell
Dario ScimecaGeneral Counsel and Secretary2025-01-228,928$4.79
$42.77kSell

1 of 2

DTIL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DTIL insiders and whales buy or sell their stock.

DTIL Shareholders

What type of owners hold Precision Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pharma Ag Novartis111.90%12,407,440$55.21MInsider
Venbio Global Strategic Fund LP38.47%4,265,141$18.98MInsider
Derek Jantz36.57%4,055,174$18.05MInsider
Fmr LLC33.71%3,738,248$16.64MInsider
Matthew R. Kane18.26%2,024,438$9.01MInsider
Lynx1 Capital Management LP6.91%766,051$3.41MInstitution
Aquilo Capital Management LLC6.55%726,149$3.23MInstitution
Tang Capital Management LLC6.07%673,332$3.00MInstitution
Vanguard Group Inc2.53%281,083$1.25MInstitution
Acadian Asset Management LLC2.24%248,620$1.11MInstitution

1 of 3

DTIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DTIL12.12%87.88%Net SellingNet Selling
SNTI18.72%81.28%Net Buying
SER0.84%99.16%Net BuyingNet Buying
IPSC34.32%45.52%Net SellingNet Selling
RNXT27.55%11.41%Net BuyingNet Buying

Precision Biosciences Stock Ownership FAQ

Who owns Precision Biosciences?

Precision Biosciences (NASDAQ: DTIL) is owned by 34.15% institutional shareholders, 247.53% Precision Biosciences insiders, and 0.00% retail investors. Pharma Ag Novartis is the largest individual Precision Biosciences shareholder, owning 12.41M shares representing 111.90% of the company. Pharma Ag Novartis's Precision Biosciences shares are currently valued at $57.57M.

If you're new to stock investing, here's how to buy Precision Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.